Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Torrent Pharmaceuticals Ltd ( (IN:TORNTPHARM) ) just unveiled an announcement.
Torrent Pharmaceuticals Limited announced that India Ratings and Research has affirmed its existing banking facilities, issuer rating and outstanding non-convertible debentures at IND AA+ with a Stable outlook, while assigning a top short-term rating of IND A1+ to its proposed commercial paper programme. The affirmation and strong short-term rating signal continued confidence in Torrent Pharma’s credit profile, support its access to bank funding and capital markets on favourable terms, and underscore the company’s solid financial position for ongoing operations and future funding needs.
More about Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company engaged in the development, manufacturing and marketing of branded and generic medicines. The company focuses on both domestic and international markets through a mix of formulations and other pharmaceutical products, serving multiple therapeutic segments and institutional as well as retail customers.
Average Trading Volume: 6,227
Technical Sentiment Signal: Buy
Current Market Cap: 1300.2B INR
Learn more about TORNTPHARM stock on TipRanks’ Stock Analysis page.